Aijun Zhou

1.4k total citations · 1 hit paper
20 papers, 962 citations indexed

About

Aijun Zhou is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Aijun Zhou has authored 20 papers receiving a total of 962 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 7 papers in Oncology and 7 papers in Cancer Research. Recurrent topics in Aijun Zhou's work include RNA modifications and cancer (5 papers), Cancer Cells and Metastasis (3 papers) and Cancer-related molecular mechanisms research (3 papers). Aijun Zhou is often cited by papers focused on RNA modifications and cancer (5 papers), Cancer Cells and Metastasis (3 papers) and Cancer-related molecular mechanisms research (3 papers). Aijun Zhou collaborates with scholars based in China, Japan and United Kingdom. Aijun Zhou's co-authors include Wen Ni, Yunxia Zhou, Liheng Che, Piao Huang, Yuanyuan Liu, Su Yao, Jianming Li, Jingwen Liu, Jian‐Ming Li and Rong Zhou and has published in prestigious journals such as American Journal Of Pathology, International Journal of Cancer and Molecular Cancer.

In The Last Decade

Aijun Zhou

17 papers receiving 955 citations

Hit Papers

Long noncoding RNA GAS5 inhibits progression of colorecta... 2019 2026 2021 2023 2019 100 200 300 400

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Aijun Zhou China 11 739 558 169 101 91 20 962
Tiankun Lu China 10 519 0.7× 337 0.6× 134 0.8× 111 1.1× 45 0.5× 10 729
Rongfang He China 15 651 0.9× 540 1.0× 99 0.6× 62 0.6× 104 1.1× 42 859
Li‐ping Gong China 16 311 0.4× 265 0.5× 199 1.2× 82 0.8× 65 0.7× 43 717
Mariana D. Mandler United States 7 697 0.9× 217 0.4× 93 0.6× 43 0.4× 45 0.5× 9 813
Fulvio Santacatterina Spain 13 570 0.8× 205 0.4× 39 0.2× 97 1.0× 45 0.5× 18 762
Jiahang Sun China 12 362 0.5× 223 0.4× 53 0.3× 53 0.5× 25 0.3× 30 530
Jialu Li China 13 523 0.7× 394 0.7× 80 0.5× 57 0.6× 46 0.5× 27 732
Dawei Chen China 12 335 0.5× 143 0.3× 82 0.5× 66 0.7× 32 0.4× 21 507
Jinghan Wang China 17 569 0.8× 289 0.5× 149 0.9× 47 0.5× 68 0.7× 41 881

Countries citing papers authored by Aijun Zhou

Since Specialization
Citations

This map shows the geographic impact of Aijun Zhou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Aijun Zhou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Aijun Zhou more than expected).

Fields of papers citing papers by Aijun Zhou

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Aijun Zhou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Aijun Zhou. The network helps show where Aijun Zhou may publish in the future.

Co-authorship network of co-authors of Aijun Zhou

This figure shows the co-authorship network connecting the top 25 collaborators of Aijun Zhou. A scholar is included among the top collaborators of Aijun Zhou based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Aijun Zhou. Aijun Zhou is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Xu, Yuanyuan, Chao Qin, Qi Wu, et al.. (2025). NSUN5 Mediates Resistance to Doxorubicin via Up-regulation of DNA Damage Repair Proteins BRCA2 and BRIP1 in Colorectal Cancer. American Journal Of Pathology. 195(10). 1921–1935. 1 indexed citations
2.
Ni, Wen, Yuanyuan Xu, Yuqing Li, et al.. (2025). Lipid deposition promotes YTHDF3-mediated m6A modification of PPARα to facilitate liver metastasis of colorectal cancer. Protein & Cell. 17(3). 190–211.
5.
Yu, Hao, Ziming Li, Jian‐Ming Yang, et al.. (2023). EphB6 deficiency in intestinal neurons promotes tumor growth in colorectal cancer by neurotransmitter GABA signaling. Carcinogenesis. 44(8-9). 682–694. 5 indexed citations
6.
Zhou, Aijun, et al.. (2022). miR-1266-3p Suppresses Epithelial-Mesenchymal Transition in Colon Cancer by Targeting P4HA3. Analytical Cellular Pathology. 2022. 1–15. 4 indexed citations
7.
Zhou, Rong, Wen Ni, Chao Qin, et al.. (2022). A functional loop between YTH domain family protein YTHDF3 mediated m6A modification and phosphofructokinase PFKL in glycolysis of hepatocellular carcinoma. Journal of Experimental & Clinical Cancer Research. 41(1). 334–334. 42 indexed citations
9.
Zhou, Aijun, et al.. (2021). Prolyl 4-hydroxylase subunit alpha 3 facilitates human colon cancer growth and metastasis through the TGF-β/Smad signaling pathway. Pathology - Research and Practice. 230. 153749–153749. 18 indexed citations
10.
Ni, Wen, Hui Mo, Yuanyuan Liu, et al.. (2021). Targeting cholesterol biosynthesis promotes anti-tumor immunity by inhibiting long noncoding RNA SNHG29-mediated YAP activation. Molecular Therapy. 29(10). 2995–3010. 73 indexed citations
11.
Che, Liheng, Jingwen Liu, Jian-Ping Huo, et al.. (2021). A single-cell atlas of liver metastases of colorectal cancer reveals reprogramming of the tumor microenvironment in response to preoperative chemotherapy. Cell Discovery. 7(1). 80–80. 118 indexed citations
12.
Liu, Zhihua, Mei‐Ling Chen, Qi Zhang, et al.. (2020). ZIC2 is downregulated and represses tumor growth via the regulation of STAT3 in breast cancer. International Journal of Cancer. 147(2). 505–518. 24 indexed citations
13.
Li, Ying, Zheng-Yi Luo, Jian‐Ming Yang, et al.. (2020). The gut microbiota regulates autism-like behavior by mediating vitamin B6 homeostasis in EphB6-deficient mice. Microbiome. 8(1). 120–120. 102 indexed citations
14.
Ni, Wen, Su Yao, Yunxia Zhou, et al.. (2019). Long noncoding RNA GAS5 inhibits progression of colorectal cancer by interacting with and triggering YAP phosphorylation and degradation and is negatively regulated by the m6A reader YTHDF3. Molecular Cancer. 18(1). 143–143. 465 indexed citations breakdown →
15.
Zhang, Xiaoping, Guiqin Li, Yue Chen, et al.. (2019). The efficacy and safety of one-stage endoscopic treatment for ascending acute cholangitis caused by choledocholithiasis with severe comorbidities. Surgical Endoscopy. 34(9). 3963–3970. 9 indexed citations
16.
Li, Guiqin, et al.. (2019). SOX9 promotes epithelial‑mesenchymal transition via the Hippo‑YAP signaling pathway in gastric carcinoma cells. Oncology Letters. 18(1). 599–608. 31 indexed citations
17.
Han, Ping, Yu Zhang, Yongdong Liu, et al.. (2018). Overexpression of Nogo receptor 3 (NgR3) correlates with poor prognosis and contributes to the migration of epithelial cells of nasopharyngeal carcinoma patients. Journal of Molecular Medicine. 96(3-4). 265–279. 11 indexed citations
18.
Zhou, Aijun, Danian Dai, Qian Zhong, et al.. (2018). High expression of TACC2 in hepatocellular carcinoma is associated with poor prognosis. Cancer Biomarkers. 22(4). 611–619. 7 indexed citations
19.
Lin, Hai, et al.. (2018). MiR-324-5p reduces viability and induces apoptosis in gastric cancer cells through modulating TSPAN8. Journal of Pharmacy and Pharmacology. 70(11). 1513–1520. 24 indexed citations
20.
Du, Yong, Lili Liu, Chenliang Wang, et al.. (2016). TACC3 promotes colorectal cancer tumourigenesis and correlates with poor prognosis. Oncotarget. 7(27). 41885–41897. 22 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026